Visage Imaging Receives FDA Clearance for Visage Ease Pro

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Visage Imaging Receives FDA Clearance for Visage Ease Pro

SAN DIEGO, Calif., May 18, 2015 (GLOBE NEWSWIRE) -- Visage Imaging Inc. ("Visage"), a wholly owned subsidiary of Pro Medicus Ltd. (ASX:PME), has announced it has received FDA 510(k) clearance for the use of Visage Ease Pro(TM) for mobile diagnostic interpretation of all imaging modalities except mammography. Visage Ease Pro is a core component of the Visage 7 Enterprise Imaging Platform , enabling enterprise imaging with amazingly fast, thin-client, server-side processing technology scaled to support the imaging needs of the world's largest healthcare institutions.

Visage Ease Pro is the first and only native iOS app with FDA clearance for mobile diagnostic interpretation that is a core component of an enterprise imaging platform designed for the diagnostic interpretation and clinical access of millions of imaging studies per year.

"Fundamentally, this is an announcement about freedom and ubiquitous access, where clinicians and radiologists can now securely interpret any image (other than mammography), nearly anywhere, using Visage Ease Pro. Since the earliest days of medical imaging, that has been the rallying cry for our industry, and today with Visage 7 and Visage Ease Pro, we're delivering on that promise for Visage customers around the globe," said Brad Levin, General Manager, North America and Global Head of Marketing.

Malte Westerhoff, PhD, Visage Imaging's Co-Founder and Chief Technology Officer added, "The platform responsible for the power of Visage Ease Pro is Visage 7, with its smart server-side processing capabilities. No separate servers dedicated for mobile use are required as it's all integrated into one universal viewing platform." Dr. Westerhoff continued, "This provides users the most consistent experience across the different use cases, and importantly, makes the solution efficient to deploy and maintain for the IT department. Visage 7 and Visage Ease Pro have been designed to scale to the largest enterprises. Tens of millions of annual studies can be processed by a single Visage 7 system for high-volume diagnostic interpretation by hundreds of radiologists, clinical review by tens of thousands of clinicians, and now with Visage Ease Pro, near anywhere mobile diagnostic interpretation."

As a native iOS application, Visage Ease Pro has been optimized for simple, fast access to images and reports. To support diagnostic interpretation, Visage Ease Pro requires the end user perform necessary calibration checks to ensure the display and environmental conditions are sufficient for diagnostic interpretation. Due to Visage 7's use of server-side processing, Visage Ease Pro can display even the largest multi-gigabyte-sized studies without performance degradation even over cellular networks. Visage Ease Pro includes numerous image manipulation features, display of non-DICOM (and non-diagnostic) images, support for recording voice memos, and the ability to upload photo attachments to studies on Visage 7. Visage Ease Pro also takes full advantage of the flexibility of iOS, offering customers the use of iOS Push Notifications, novel app-to-app integration via the use of the Visage 7 protocol handler, and for discriminating IT organizations, secure multi-factor authentication with integration to Active Directory. This robust level of native app integration and overall usability is not found when competing browser-based image viewers are used on mobile devices.

Consistent with general FDA principles for mobile apps, mobile devices should only be used for diagnosis in situations where no full diagnostic workstation is available (and not for mammography). Diagnostic interpretation using Visage Ease Pro should also only be performed on iPads due to the available screen real estate, with a user alert displayed when Visage Ease Pro is used on the iPhone.

Visage Ease Pro is a free download from the Apple App Store, and requires Visage 7.1.6 (or later) for use. Visage Ease Pro is also available for download via the Apple App Store for Canada, Australia and EU-countries (that accept English or German as languages of the IFU). Visage Ease Pro has been registered by Health Canada, TGA Australia and has received the CE Mark for mobile diagnostic use of imaging modalities other than mammography.

In addition to Visage Ease Pro, Visage also offers Visage Ease(SM) for mobile access to images and reports. Available since June 2011, Visage Ease will continue to be supported and is intended for education and illustration purposes only. Visage Ease is not a medical device and must not be used for diagnosis. In contrast to Visage Ease Pro, Visage Ease does not require calibration checks to ensure the display and environmental conditions are sufficient for viewing, which is attractive for physicians who are not reading diagnostically on their mobile devices.

For more information about Visage Ease Pro, please visit the Visage Imaging exhibit at this week's ACR 2015 in Washington, DC (Marriott Wardman Park, Visage Booths 506/508, May 17-21), as well as the upcoming SIIM 2015, also in Washington, DC (Gaylord National Harbor, Visage Booths 406/408, May 28-30). To schedule a priority demonstration of Visage 7, please visit http://www.visageimaging.com/events/ .

About Visage Imaging, Inc.

Visage Imaging is a global provider of enterprise imaging and advanced visualization solutions for diagnostic imaging. Visage 7 delivers amazingly fast server-side rendered images streamed via an intelligent thin-client viewer. Radiologists and referring physicians have a customized, protocol-driven workflow to natively view multi-dimensional imagery across a single desktop. Powerful imaging solutions include enterprise viewing and interpretation; image enablement of EMRs, VNAs, HIEs and portals; RIS/PACS, as well as anywhere mobile diagnostic access. http://www.visageimaging.com

About Pro Medicus Limited

Pro Medicus Limited [ASX: PME] is Australia's leading imaging IT provider. Founded in 1983, the company provides a full range of integrated software products and services to hospital, imaging centers and health care groups worldwide. http://www.promed.com.au

Contacts: Brad Levin, General Manager, North America and Global Head of Marketing Visage Imaging, Inc. Phone: (540) 454-9670 E-mail: blevin@visageimaging.com

Visage, Visage Imaging, Visage Ease Pro, Visage Ease, ANV, and Deconstructed PACS are trademarks, registered trademarks and service marks that are licensed by Visage Imaging Inc. Other product and company names mentioned may be trademarks and/or registered trademarks of their respective owners or licensees.

This article was originally distributed on PRWeb. For the original version including any supplementary images or video, visit http://www.prweb.com/releases/2015/05/prweb12729399.htm

Visage Imaging Brad Levin +1 (540) 454-9670

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Charter Investigation Puts ACP Exit Claims Under Lens

Updated Category News Views 105

Charter’s ACP hangover has grown from an operating headache into a governance question. Kahn Swick & Foti said on November 20, 2026, that it has begun investigating whether Charter Communications officers or directors breached fiduciary duties or otherwise broke state or federal law. That is not a finding of wrongdoing, and investors ought to keep that distinction...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 69

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
Cottage Grove Tests Holiday Demand Across Lake Norman

Updated Category News Views 125

Flour and foot traffic make a pretty honest little scoreboard. Cottage Grove Bakery is putting itself in front of Lake Norman shoppers twice on Saturday, November 21, while also taking Thanksgiving orders and laying groundwork for 2027 workplace and school visits. This is not a public-company earnings story, and nobody should pretend a tray of scones is a quarterly...

Continue Reading
TEN Holdings Raises $1.0 Million as Dilution Looms

Updated Category News Views 73

A Small Raise With a Loud Message Nothing says “we need room to breathe” quite like selling 1,492,500 new shares for $0.67 apiece. TEN Holdings closed a roughly $1.0 million gross equity offering on November 20, 2026, and investors in NASDAQ:XHLD ought to look at this for what it is: a modest cash infusion that comes with immediate dilution. The company gets capital;...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 107

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
California Initiative Puts Missed Diagnoses in Focus

Updated Category News Views 73

When Reassurance Turns Into a Risk A clean scan can become a dangerous lullaby when symptoms refuse to leave. That is the hard, unsettling territory behind Hodes Milman’s new Missed Diagnosis Project: California, launched November 20, 2026. The statewide effort focuses on breast cancer diagnostic failures: scans read as benign when more scrutiny was warranted, referrals...

Continue Reading
S&P Global's UBS AI Conference Slot Deserves Attention

Updated Category News Views 119

Thirty Minutes Can Still Matter A half-hour fireside chat is not a quarterly earnings call, and anybody treating it like one is setting themselves up for disappointment. Still, S&P Global CEO Martina Cheung appearing at the UBS Global Technology and AI Conference on December 2 deserves a spot on the calendar for owners of NYSE:SPGI. This is a company sitting in the middle...

Continue Reading
Allooloo's 100M Calls Test Capital Markets AI Data

Updated Category News Views 160

Forty-one point nine thousand issuers is a lot of financial clutter to keep straight, and Allooloo says its machines are getting called on to do precisely that at industrial scale. The Vancouver-based company reported on November 20 that its capital-markets data products now receive 100 million AI-agent calls a month—roughly 3.4 million daily, or 39 per second. That is...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 93

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 69

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading

Top 5 Most Recently Viewed Articles

Mauna Kea Technologies Advances AI Integration in Endomicroscopy

Updated Category News Views 512

Mauna Kea Technologies and its Innovative AI Patent Mauna Kea Technologies, the proud inventor of Cellvizio®, a revolutionary platform that blends probe and needle-based confocal laser endomicroscopy (p/nCLE), has taken a significant step forward in the realm of artificial intelligence in medical diagnostic procedures. Recently, the company announced the granting of a...

Continue Reading
Hot Chili Limited Secures Approval for La Verde Expansion Drilling

Updated Category News Views 168

Hot Chili Limited's Significant Progress at La Verde Hot Chili Limited (OTCQX: HHLKF) has obtained key regulatory approval to enhance the drill coverage of its La Verde copper-gold discovery. This exciting development comes as the company aims to broaden exploration activities in an area strategically important to its operations. Understanding the La Verde Project The La...

Continue Reading
Investors on High Alert as Lithium Faces Growing Demand Challenges

Updated Category News Views 261

The Lithium Debate: Rising Tensions at COP30 At the recent climate discussions, the dialogue took an unexpected turn, raising eyebrows among investors in various clean-tech sectors. For the first time in thirty years of United Nations climate negotiations, serious concerns emerged regarding the social and environmental risks associated with lithium mining, which is...

Continue Reading
Edible Garden Expands USDA Organic Herb Line in New Markets

Updated Category News Views 71

Introducing Edible Garden's Organic Product Line Edible Garden AG Incorporated has been making headlines as a leader in controlled environment agriculture (CEA). Recently, they launched their USDA Organic herb product line at Green’s Natural Foods and The Extra Supermarket, which is a significant step in their mission to provide sustainably grown and organic produce....

Continue Reading
Growth Surge: The Value of $100 Investment in Riot Platforms

Updated Category News Views 148

Understanding the Rise of Riot Platforms Investors seeking substantial growth often look to companies like Riot Platforms (NASDAQ: RIOT), which has demonstrated impressive performance over the past five years. With a remarkable annualized return of 46.95%, Riot has outpaced the market by over 34.28%. This consistent growth contributes to a current market capitalization of...

Continue Reading